Can cabbage soup really boost GLP-1 like Ozempic does?

What did @cookingforpeanuts actually say?

Nisha, a self-described registered dietitian, made two big claims: that cabbage can "help with weight management" and can "cut the risk of cancer progression by more than half." She also frames the recipe as a cheaper alternative to Ozempic, implying dietary fiber raises the body's own GLP-1 production enough to matter clinically. Those are very different claims, and they deserve to be treated separately.

To be fair, she did not say cabbage replaces semaglutide directly in her spoken words. That framing lives in the caption, not the transcript. But by opening with "Ozempic is expensive" and pivoting to cabbage soup, the implied message is clear: eat this and your body will do what the drug does. That is a leap the evidence does not cleanly support.

The cancer claim is the one that should raise eyebrows immediately. "Cut the risk of cancer progression by more than half" is a precise-sounding statistic. Precise statistics need precise sources.

Does the science back this up?

On fiber and GLP-1: yes, there is real science here, but the effect size is modest. Fermentable fiber is broken down by gut bacteria into short-chain fatty acids, which stimulate L-cells in the intestinal wall to secrete GLP-1. This is not controversial. What is contested is whether the resulting GLP-1 bump is anywhere near pharmacologically meaningful compared to injecting a GLP-1 receptor agonist.

Drucker (2018, Cell Metabolism) and a 2022 review by Chambers et al. in Gut both confirm that high-fiber diets can raise postprandial GLP-1 levels. But the magnitude is a fraction of what semaglutide achieves. Semaglutide works partly by blocking GLP-1 degradation and binding receptors with far greater affinity than endogenous GLP-1. You cannot replicate that pharmacology with cabbage.

On cancer: a 2012 meta-analysis by Liu et al. in the Annals of Oncology found cruciferous vegetable consumption associated with reduced colorectal cancer risk, but the effect sizes were modest and the evidence was observational. No study I can find supports "more than half" reduction in cancer progression as a general claim across cancer types.

What did they get wrong (or right)?

She got the fiber-GLP-1 mechanism directionally right. Fiber does stimulate GLP-1 release. That part is real science. Credit where it is due.

The cancer claim is where she goes off the rails. "Cut the risk of cancer progression by more than half" is not a defensible general statement. Some observational studies show associations between cruciferous vegetables and reduced risk of specific cancers, particularly colorectal and bladder cancers. But association is not causation, the effect sizes vary widely, and "progression" is a clinical term that refers to an existing cancer getting worse, not to initial risk. The number cited sounds authoritative but appears unanchored to any single study.

The Ozempic framing in the caption is also misleading. Eating fiber-rich foods is genuinely good for metabolic health. But implying that a bowl of cabbage soup is a meaningful substitute for a GLP-1 receptor agonist sets up people who cannot afford medication with false expectations. That is a real harm, even when wrapped in a nice recipe.

What should you actually know?

Cabbage is a legitimately healthy food. It is cheap, high in fiber, contains glucosinolates that have shown anti-inflammatory properties in cell studies, and fits well into a diet that supports metabolic health. Eating more of it is not a bad idea for most people.

But "supports metabolic health" and "replaces Ozempic" are not the same sentence. GLP-1 receptor agonists produce 10-15% body weight loss on average in clinical trials (Wilding et al., 2021, NEJM). No dietary intervention has matched that in head-to-head trials. People with obesity-related conditions or type 2 diabetes considering GLP-1 medications deserve accurate information about what food can and cannot do.

If you genuinely cannot afford semaglutide or tirzepatide, the conversation to have is with a prescriber about patient assistance programs, biosimilar timelines, or whether a different medication class is appropriate. A cabbage soup, however delicious, is not that conversation.

• Fiber does stimulate GLP-1 secretion through short-chain fatty acid production in the gut.
• The GLP-1 increase from dietary fiber is real but not comparable to the receptor-level pharmacology of GLP-1 agonist medications.
• The cancer claim as stated is imprecise and unsupported as a general statistic.
• Cabbage and cruciferous vegetables have genuine evidence for modest cancer risk reduction in observational data, particularly for colorectal cancer.